Indeed, crosstalk occurred between IGF-1R and HER2, and IGF-1R physically interacted with HER2 and induced HER2 activation in Herceptin-resistant, but not -sensitive breast cancer cells23. The gene discussed is IGF1R; the disease is breast carcinoma.